1. Home
  2. UPC vs BCLI Comparison

UPC vs BCLI Comparison

Compare UPC & BCLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UPC
  • BCLI
  • Stock Information
  • Founded
  • UPC 1998
  • BCLI 2000
  • Country
  • UPC China
  • BCLI United States
  • Employees
  • UPC N/A
  • BCLI N/A
  • Industry
  • UPC Biotechnology: Pharmaceutical Preparations
  • BCLI Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • UPC Health Care
  • BCLI Health Care
  • Exchange
  • UPC Nasdaq
  • BCLI Nasdaq
  • Market Cap
  • UPC 6.6M
  • BCLI 6.4M
  • IPO Year
  • UPC 2021
  • BCLI N/A
  • Fundamental
  • Price
  • UPC $0.14
  • BCLI $1.21
  • Analyst Decision
  • UPC
  • BCLI Strong Buy
  • Analyst Count
  • UPC 0
  • BCLI 1
  • Target Price
  • UPC N/A
  • BCLI $30.00
  • AVG Volume (30 Days)
  • UPC 803.8K
  • BCLI 118.2K
  • Earning Date
  • UPC 01-01-0001
  • BCLI 11-14-2024
  • Dividend Yield
  • UPC N/A
  • BCLI N/A
  • EPS Growth
  • UPC N/A
  • BCLI N/A
  • EPS
  • UPC N/A
  • BCLI N/A
  • Revenue
  • UPC $26,725,919.00
  • BCLI N/A
  • Revenue This Year
  • UPC N/A
  • BCLI N/A
  • Revenue Next Year
  • UPC N/A
  • BCLI N/A
  • P/E Ratio
  • UPC N/A
  • BCLI N/A
  • Revenue Growth
  • UPC N/A
  • BCLI N/A
  • 52 Week Low
  • UPC $0.12
  • BCLI $1.05
  • 52 Week High
  • UPC $4.32
  • BCLI $11.85
  • Technical
  • Relative Strength Index (RSI)
  • UPC 20.65
  • BCLI 23.69
  • Support Level
  • UPC $0.22
  • BCLI $1.05
  • Resistance Level
  • UPC $0.29
  • BCLI $1.95
  • Average True Range (ATR)
  • UPC 0.03
  • BCLI 0.20
  • MACD
  • UPC 0.02
  • BCLI -0.00
  • Stochastic Oscillator
  • UPC 10.30
  • BCLI 15.84

About UPC Universe Pharmaceuticals Inc.

Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.

About BCLI Brainstorm Cell Therapeutics Inc.

Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.

Share on Social Networks: